Introduction
The JAK/STAT signal transduction cascade was ®rst identi®ed in mammalian systems because of its role in the transduction of a variety of cytokines and growth factor signals (reviewed in Darnell, 1997) . Extensive studies in mammalian systems have led to the development of a canonical model in which the nonreceptor tyrosine kinase JAK is associated with the intracellular portion of transmembrane cytokine receptors ( Figure 1a) . Following ligand binding, receptors dimerize bringing two JAK molecules into juxtaposition where they trans-phosphorylate one another. JAKs activated in this manner then tyrosine phosphorylate their associated receptors causing normally cytosolic STAT molecules to bind to the receptor complex via their SRC homology 2 (SH2) domains. The STAT molecules recruited in this manner are themselves activated by JAK-mediated phosphorylation of an invariant tyrosine residue in their C-terminal region and then either homo-or hetero-dimerize prior to nuclear translocation. Once in the nucleus activated STAT dimers bind to consensus DNA target sites where they act as activators of transcription ( Figure 1a and other reviews in this issues).
Interestingly the JAK/STAT pathway and STATlike molecules in particular are present throughout evolution. To date one (or possibly two) STATs have been found in the nematode C. elegans (Lui et al., 1999) , and three STAT-like molecules have been identi®ed in the slime mould Dictyostelium (M Fukazawa and JG Williams, unpublished data reported in Williams, 1999) . However, neither organism appears to have JAK-like protein kinases.
In the Drosophila system a`complete' JAK/STAT pathway that consists of one JAK (called hopscotch) and one STAT (called stat92E) has been identi®ed, in stark contrast to the multitude of JAK and STAT homologues present in mammals. The presence of a relatively simple JAK/STAT pathway, together with the wealth of sequence data and genetic techniques available, make Drosophila a very powerful system with which to study this pathway. These advantages, especially with respect to developmental requirements for JAK/STAT signaling, are particularly relevant for the¯y model system and hold much promise for the future elucidation of interactions between the JAK/ STAT pathway and other signal transduction cascades involved in developmental decisions.
In this review we discuss recent developments into our understanding of the components and roles of the JAK/STAT pathway during Drosophila development and address potential future directions in the ®eld.
Characterization of Drosophila JAK/STAT pathway components
With the recent cloning of unpaired (upd) and its identi®cation as a potential ligand for the Drosophila JAK/STAT pathway (Harrison et al., 1998) , three pathway components have been identi®ed on the basis of their biochemical, genetic and mutant phenotypes.
The hopscotch (hop) locus encodes a 1177 amino acid protein that shares all the characteristics of mammalian JAK family non-receptor tyrosine kinases. Hop is most similar to human JAK2 (27% identity), with higher levels of homology in kinase and kinase-like domains (Figure 1b, Binari and Perrimon, 1994) . The Drosophila STAT homologue Stat92E is also highly homologous to human STAT5 (37% identity). Stat92E includes a SH2 domain, DNA binding domain and the single tyrosine residue around position 700 found in all STAT-like genes (Figure 1b, Hou et al., 1996; Yan et al., 1996a) . Indeed this residue in Stat92E (Y711) has been shown to be phosphorylated in response to Oncogene (2000) 19, 2598 ± 2606 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc *Correspondence: N Perrimon pathway activation in tissue culture systems (Yan et al., 1996a) .
It has previously been reported that a second, nonStat92E derived STAT-like activity is detectable in Drosophila cell extracts (Yan et al., 1996a; Sweitzer et al., 1995) . A series of searches of the Drosophila genome sequencing project data were therefore conducted on a complete 106 coverage database to address this question. Using Stat92E protein sequences as`probes' for tblastn search programs no candidate STAT-like molecules, other than stat92E itself, were identi®ed (E Spana, personal communication). While, it remains possible that a STAT-like protein, which has diverged suciently far from Stat92E to be undetectable with sequence based searches, is in fact present, it seems that the complex situation in vertebrate model systems is not mirrored in Drosophila. Therefore both Hopscotch and Stat92E probably represent the sole examples of canonical JAK-and STAT-like proteins present in¯ies.
While mutations in the unpaired locus have been known for over 75 years, only recently has the associated gene been identi®ed as a ligand for the Drosophila JAK/STAT pathway (Venderosa and Muller, 1954; Harrison et al., 1998) . The unpaired locus encodes a predicted 47 kDa secreted protein with an N-terminal signal sequence and several potential Nlinked glycosylation sites (Figure 1b) . While a protein similar to Upd called Om1E has been identi®ed in the closely related fruit¯y Drosophila ananassae, no known vertebrate homologues have been found in publicly available databases to date (Harrison et al., 1998; Juni et al., 1996) . Biochemical analysis of Upd revealed that the protein has an apparent molecular weight of 65 kDa, is indeed glycosylated and is localized in the extracellular matrix. Furthermore, tissue culture experi- (Harrison et al., 1998) . Taken together with in vivo evidence showing that Upd functions as an activator of JAK/STAT signaling in the eye (Zeidler et al., 1999b) , it is clear that Unpaired represents a bona ®de JAK/STAT pathway ligand.
Although the identity of Drosophila JAK and STAT homologues and a pathway ligand are now known, the identity of a pathway receptor(s) remains unclear. Vertebrate studies have shown that the JAK/STAT pathway is downstream of cytokine receptors and receptor tyrosine kinases such as EGFR and PDGFR (Darnell, 1997) . While a similar situation may also be the case in Drosophila no evidence had emerged to date regarding the nature of a potential pathway receptor.
Fly homologues of other components of the mammalian JAK/STAT pathway, speci®cally PIAS, SOCS, and STAM, have also been identi®ed. Two of these are homologues of previously identi®ed negative regulators of the mammalian JAK/STAT pathway; Protein Inhibitor of Activated STAT (PIAS) and Suppressor Of Cytokine Signaling (SOCS). PIAS proteins contain a putative zinc-®nger domain, and speci®c PIAS proteins bind to and inhibit the activity of speci®c STATs (Chung et al., 1997) . In Drosophila, a PIAS homologue named zimp, has been identi®ed by sequence homology and although mutations are lethal, no further functional data has been published. It is therefore not yet clear whether this protein inhibits the activity of Stat92E (Mohr and Boswell, 1999) . The SOCS family of proteins are characterized by the presence of a highly conserved 40-amino acid Cterminal SOCS domain preceded by an SH2 domain (Nicholson et al., 1999) . Studies indicate that SOCS proteins can inhibit cytokine signaling either directly by inhibition of JAKs or indirectly by competition with STAT for a phospho-tyrosine binding site on the receptor. Interestingly a¯y homologue of SOCS-5 has recently been identi®ed, that retains sequence identity in both the SH2 domain and regions previously identi®ed as being required for SOCS activity (Nicholson et al., 1999) . Currently there are no mutations in the Drosophila SOCS gene, and thus the physiological function of this gene is presently not known. The ®nal Drosophila homologue to human pathway components is the Signal Transducing Adaptor Molecule (STAM). STAMs were originally identi®ed as positive regulators of cytokine-dependent signal transduction, contain a SRC homology 3 (SH3) domain and associate with Jak2 and Jak3 (Takeshita et al., 1997) . The¯y homologue of STAM, also called stam, was cloned by homology, and again no functional data is available for this gene (MesilatyGross et al., 1999) . Future genetic and biochemical characterization of these Drosophila homologues may establish that Drosophila PIAS, SOCS and STAM are true orthologues and represent additional levels of JAK/STAT pathway complexity in the¯y model system.
Sex determination
The sisterless C (sisC) gene has been known for some time as a component of the Drosophila sex determination system (Cline, 1993) and the recent identi®cation of sisC as an allele of Upd has implicated the JAK/ STAT pathway in one of the earliest processes of embryonic development.
The process of sexual identity determination in Drosophila is based on very early mechanisms which detect the X chromosome to autosome ratio of the newly fertilized embryo (with XY individuals becoming males and XX developing into females). The cellular mechanism which determines the number of X chromosomes establishes the expression state of the Sex lethal gene which acts as a`master switch' to determine sexual identity and X chromosome dosage compensation. The dose of X chromosomes present in a newly fertilized embryo is relayed into this sexual determination machinery via the activity of a number of X-linked signal element (XSE) genes which are encoded on the X chromosome and include sisA, sisB and sisC (see Cline, 1993 for review). The two copies of these XSE genes produced in future females is sucient to activate the`Sex lethal establishment' promoter and cause Sex lethal expression which, via a positive autoregulatory feedback loop, is then maintained throughout the life of the¯y. In future males the XSE genes present on the single X chromosome are expressed at insucient levels to activate the Sex lethal promoter.
A recent report has identi®ed the XSE gene sisC as being allelic to upd. While previously identi®ed XSE genes, sisA and sisB represent transcription factors that can bind directly to the Sex lethal promoter, sisC/upd obviously represents an extracellular JAK/STAT pathway ligand. This ®nding suggests that the JAK/STAT pathway is required for the transduction of the SisC/ Upd signal and, either directly or indirectly, controls Sex lethal expression (Thomas Cline, personal communication).
Although a similar role for the JAK/STAT pathway in sexual identity determination has not been previously described in other systems, it is clear that the mechanisms by which sexual identity is determined in other animals are very diverse. As a result it is possible that research into a potential role for the JAK/STAT pathway in sex determination will provide insights not only into the rapid evolutionary development of sexual identity, but also the mechanisms whereby established signal transduction pathways are co-opted into new developmental roles.
Embryonic segmentation
Both hopscotch and stat92E are deposited maternally in the developing oocyte during oogenesis. Hop is expressed essentially uniformly throughout the various stages of embryonic development, while Stat92E is expressed uniformly during early stages but subsequently resolves initially into seven and then 14 segmental stripes (Binari and Perrimon, 1994; Hou et al., 1996; Yan et al., 1996a) . Upd, in contrast, is not maternally supplied but is expressed from the zygotic genome in a highly dynamic pattern: broadly in the trunk and in a stripe in the head before cellularization, seven stripes during cellularization, 14 stripes during gastrulation and later in the tracheal pits (Harrison et al., 1998) . Despite these very dierent patterns of expression the three known components of the JAK/ STAT pathway exhibit very similar, loss-of-function phenotypes in the embryo. However because of the maternal contributions, the roles of hop and stat92E in the embryo can be only assessed in embryos that lack this contribution and that are derived from females with homozygous mutant germlines. Using a genetic method, the`dominant female sterile technique', which allows the generation of females that have a homozygous mutant germ-line in an otherwise wild type¯y (Chou and Perrimon, 1996) , embryos that lack maternally contributed hop or stat92E can be generated (hereafter referred to as hop and stat92E mutant embryos). It should however be noted that maternal deposition of hop and stat92E does not appear to be absolutely essential. The embryonic phenotypes associated with removal of maternally supplied hop or stat92E can be partially rescued by a wild type copy of the gene supplied paternally and also by the injection of wild type stat92E mRNA into pre-blastoderm stat92E mutant embryos (Binari and Perrimon, 1994; Hou et al., 1996) .
All embryos mutant for hop, stat92E or zygotic upd exhibit a characteristic segmentation defect. These defects are readily identi®able as a disruption in the normal pattern of hairs or denticles that make up part of the external cuticle secreted by the embryo shortly before hatching. While wild type embryos have a stereotyped arrangement of denticle belts that correspond to each thoracic and abdominal segment ( Figure  2a ), JAK/STAT mutant embryos typically exhibit a loss of the ®fth segment with variable deletion of the fourth and eighth segments, as well as occasional fusion of the sixth and seventh segments (Figure 2b; Binari and Perrimon, 1994; Harrison et al., 1998; Hou et al., 1996; Yan et al., 1996a) .
Proper segmentation of the embryo is established by several sets of temporally expressed genes. Maternal genes establish the anteroposterior and dorsoventral axes of the embryo, and along the anteroposterior axis the sequential expression and activity of zygotic segmentation genes (gap, pair-rule, and segmentpolarity) progressively re®ne the number and orientation of the segments. Mutations in the gap genes result in deletion of multiple adjacent segments, those in the pair-rule genes in deletion of alternative segments, and those in the segment polarity genes result in loss of part of each segment. However the distinctive cuticle phenotypes of upd, hop and stat92E mutant embryos are shared only by mutations now identi®ed as being components of the JAK/STAT pathway, and were therefore classi®ed as a separate class of segmentation mutants. In upd, hop and stat92E mutant embryos, the gap-genes are expressed normally. However, there are defects in the expression of the pair-rule genes evenskipped (eve), fushi tarazu and runt (Binari and Perrimon, 1994; Hou et al., 1996) .
The eect of mutations in the JAK/STAT pathway on pair rule gene expression is quite variable and depends on the stripe in question. Levels of endogenous eve stripes 3 and 5 are signi®cantly reduced in upd, hop and stat92E mutant embryos (Binari and Perrimon, 1994; Harrison et al., 1998; Hou et al., 1996; Yan et al., 1996a) . Although the regulatory domains controlling stripe 5 have not been identi®ed, a 500 bp regulatory sequence in the eve promoter has been de®ned that controls expression of eve stripe 2, 3 and 7 (Binari and Perrimon, 1994; Small et al., 1996) . When this enhancer is fused to a lacZ reporter and introduced into wild type embryos b-galactosidase activity is detected in three stripes corresponding to (Figure 2c) . When this enhancer, is introduced into upd, hop or stat92E mutant embryos, expression of stripe 3 is almost completely abolished (Figure 2d ; Binari and Perrimon, 1994; Hou et al., 1996; Harrison et al., 1998) . This enhancer contains two sequences that closely resemble the mammalian consensus STAT binding site, and in vitro assays indicate that, tyrosine-phosphorylated, activated stat92E can bind to these sites. Moreover, when these STAT-binding sites are mutated, the 500 bp enhancer no longer drives eve stripe 3 expression. Taken together these results indicate that the JAK/STAT pathway is directly required for expression of eve stripe 3 (Hou et al., 1996; Yan et al., 1996a) .
However, the control of endogenous eve stripe 3 expression is not solely a consequence of JAK/STAT activity. Additional levels of regulation must exist as endogenous eve stripe 3 is not completely abolished in JAK/STAT pathway mutant embryos. Therefore it has been suggested that at least one additional unidenti®ed factor co-operates with Stat92E to activate stripe 3 expression in the embryo. Similarly, because the expression of stripe 7, as reported by the 500 bp enhancer, is not diminished in upd, hop or stat92E mutant embryos, another unidenti®ed co-activator that acts within the enhancer element to control stripe 7 expression must also exist.
The analysis of eve stripe 3 regulation by JAK/STAT pathway has led to the model that this pathway plays a permissive, and not an instructive, role in embryonic patterning at this stage. In this model, the pathway acts to potentiate and amplify an unknown factor that drives eve stripe 3 expression rather than being responsible for the generation of the primary signal that positions eve stripe 3 directly. Genetic analysis supports this view and has shown that the anterior and posterior domains of eve stripe 3 expression are controlled by the Hunchback and Knirps proteins, both of which are transcriptional repressors. Removal of Hunchback expands the domain of stripe 3 anteriorly while removal of Knirps expands it posteriorly. When both repressors are removed, stripe 3 expands in both directions and is expressed throughout the embryo. Therefore, because the borders of eve stripe 3 expression are already tightly controlled by Hunchback and Knirps, the JAK/STAT pathway does not have to be activated in a spatially restricted domain. Consistent with this model, precise spatial activation of the JAK/STAT pathway by the ligand Upd does not appear to be essential for proper segmentation.
The JAK/STAT pathway and larval hematopoiesis
As is also the case in mammalian systems, a requirement for the JAK/STAT pathway during Drosophila hematopoiesis has also been established. Although there are many unresolved issues about the ontogeny of the cells in Drosophila hemolymph, it is thought that the larval hematopoietic organ, the lymph gland, gives rise to plasmatocytes which make up approximately 90% of the circulating cells in the larva. Plasmatocyes are phagocytic cells that play an important role in immune defense and cell-scavenging, and it is these cells which then terminally dierentiate into encapsulating lamellocytes, at the end of larval development (see Mathey-Prevot and Perrimon, 1998, for recent review).
One of the ®rst indications that the JAK/STAT pathway is critical to the development of these circulating cells was the identi®cation of dominant gain-of-function alleles of hop. Two temperature sensitive mutations in the hop locus have been identi®ed that result in proteins with constitutively hyperactivated kinase activity. The hop Tum-l allele is a point mutation (G431E, see Figure 1b ) of a residue otherwise unconserved in other JAKs (Hanratty and Dearolf, 1993) . The other, hop
T42
, is slightly stronger than hop Tum-l and also contains a single amino acid substitution (E695K, see Figure 1b ) present in the kinase-like domain and represents the mutation of a residue conserved in all known JAK homologues (Luo et al., 1997) . These substitutions represent the only hyper-activating mutations currently identi®ed in any JAK kinase. An equivalent substitution to the hop Tum-l allele engineered into murine JAK2 results in similar overactive molecules (Luo et al., 1997) . hop Tum-l individuals form 5 ± 20-fold more plasmatocytes when raised above the restrictive temperature. Many of these prematurely dierentiate into lamellocytes, form large aggregates and are encapsulated to form melanotic tumors. When transplanted into a wild type host, hop Tum-l hypertrophied larval lymph glands retain the ability to cause overproliferation of plasmatocytes and melanotic tumors (Hanratty and Dearolf, 1993; Harrison et al., 1995; Luo et al., 1995) .
Overexpression experiments have also shown that wild type hop misexpression can also produce a melanotic blood cell tumor phenotype similar to hop Tum-l . Furthermore, both hop overexpression and hop Tum-l -induced melanotic blood cell tumor phenotypes can be suppressed by the removal of a copy of the stat92E locus, and the resultant reduction in the level of Stat92E activity. However, while Stat92E is obviously important for the melanization of tumors, it has been reported that the blood cell overproliferation phenotype is not eected by changes in Stat92E. It was therefore suggested that the pathway may bifurcate downstream of hop, proliferation being a Stat92E-independent process (Luo et al., 1995) . While this may be the case, it is also possible that proliferation is simply not as easily suppressed as the melanization by removal of a single copy of stat92E in this context.
JAK/STAT functions at other developmental stages

While Hop misexpression of Hop
Tum-l activity in the lymph gland leads to blood cell overproliferation, the situation in imaginal discs, tissue destined to form the adult¯y, is not as straightforward. Over-or misactivation of the pathway in imaginal tissue by ectopic expression of Hop or Hop Tum-l does not generally produce an overproliferation of target tissue. Rather such ectopic activation results in a range of as yet largely uncharacterized fate changes and developmental defects (Harrison et al., 1995) . While these eects are intriguing and indicative of uncharacterized roles for the JAK/STAT pathway in adult development, it does not at present appear that the JAK/STAT pathway is linked to tissue neoplasia in imaginal tissue.
Loss of Hop activity in hetero-allelic mutant combinations result in`small' or`no' disc phenotype (Perrimon and Mahowald, 1986) . In addition the removal of the hop locus from imaginal cells results in a mutant clone that is often far smaller than expected given the size of the`twin spot' WT clone produced during mitotic recombination. This indicates that these mutant cells are at a proliferative disadvantage (Luo et al., 1999, D Strutt and MP Zeidler, unpublished observations) . However it is not clear that stat92E mutant clones show a similar`undergrowth' and both hop and stat92E mutant tissue can survive and proliferate to some degree. Therefore it would seem that the JAK/STAT pathway is not absolutely required for cellular proliferation in the¯y.
While the hop Tum-l gain-of-function mutation discussed above indicates an important role for the JAK/STAT pathway during hematopoiesis, further functions for the pathway during adult development have been indicated by a range of putative regulatory and partial loss of function alleles, of pathway components, recovered by virtue of their adult phenotypes (Perrimon and Mahowald, 1986; Venderosa and Muller, 1954) . Of these, alleles of upd were originally identi®ed (and named) on the basis of their distinctive`outstretched' wing phenotype in which wings are held out from the body of the adult¯y and a`small eye' phenotype characterized by a small roughened adult eye or both`outstretched-small eye' defects (Venderosa and Muller, 1954) . All of these appear to represent regulatory alleles of the unpaired locus in which protein expression domains or levels are altered (Harrison et al., 1998) . In addition to these upd alleles a number of weak loss-of-function alleles of hop have also been identi®ed (Perrimon and Mahowald, 1986; Luo et al., 1999) . In dierent hetero-allelic combinations hop alleles can give rise to both small or no disc phenotypes as well as adult animals with held out wings and rough or disrupted eye phenotypes (Luo et al., 1999) . Finally a weak stat92E allele, called stat92E hi-jak , has also been described and shows a range of adult phenotypes, including a subtle but clearly reproducible ectopic wing vein formation (Yan et al., 1996b) .
Taken together it is clear that the components of the Drosophila JAK/STAT signaling pathway are involved in multiple aspects of adult development, including wing vein, wing hinge and eye development. However, the precise roles of the pathway in the development of these tissues remain to be characterized.
Ommatidial polarity
One adult tissue in which the role of the JAK/STAT pathway has been studied in detail is the eye. The Drosophila compound eye consists of approximately eight hundred 20-cell subunits called ommatidia that form the individual facets of the adult eye. These ommatidia are formed in the eye imaginal disc and rotate during development to assume dorsal and ventral rotational fates (shown as green and red clusters in Figure 3a ) in each hemisphere of the future eye separated by a central line of mirror image symmetry known as the equator (Figure 3a and reviewed in Wol and Ready, 1993) . It has recently been shown that there is a requirement for the JAK/ STAT pathway for the process of ommatidial rotation (Zeidler et al., 1999b) . Moreover the process of ommatidial rotation requires not only JAK/STAT activity, but also both Wingless (Heberlein et al., 1998; Wehrli and Tomlinson, 1998) , and Notch function (Cho and Choi, 1998; DomõÂ nguez and de Celis, 1998; Papayannopoulos et al., 1998) .
While clones lacking either hop or stat92E generated in the developing eye primordia are generally smaller than expected, they can proliferate and give rise to normal ommatidial clusters. Ommatidia within JAK/ STAT mutant clones contain all cell types and appear to dierentiate correctly and most rotate as anticipated. However, ommatidia situated close to the margin of large or broad mutant regions furthest from the equator often assume a 1808 inverted orientation (note red clusters in Figure 3b ). Consequently dorsally oriented ommatidia can be associated with hop clones in the ventral hemisphere of the eye and ventrally rotated ommatidia can be associated with dorsal clones (as shown in Figure 3b) . Interestingly, inverted ommatidia present near the margins of hop mutant clones do not always lack JAK/STAT signaling but are sometimes comprised exclusively of wild type cells (arrows in Figure 3b ). The fact that ommatidial clusters at this boundary composed entirely of wild type cells can still be inverted suggests that the JAK/ STAT pathway, which molecular evidence suggests should be acting autonomously (within a single cell), is actually acting in a non-autonomous manner (on neighboring cells). This unexpected non-autonomous eect of hop and stat92E mutant clones is thought to result from a second, genetically downstream diusible molecule that is controlled by the JAK/STAT pathway and is able to act non-autonomously on the juxtaposed wild type tissue.
A second signal and ommatidial polarity determination
The ®nding that clones of autonomously acting JAK/ STAT pathway components can give rise to nonautonomous ommatidial inversion phenotypes, while unexpected, is not entirely without precedent. Similar results have also been reported for the Wingless signaling pathway (Wehrli and Tomlinson, 1998) . As is the case for hop and stat92E, autonomously acting mutants of Wingless pathway components can also result in the inversion of entirely wild type ommatidia adjacent to mutant clonal areas. The existence of nonautonomous ommatidial inversion phenotypes has been interpreted to suggest that both the JAK/STAT and Wingless pathways, cannot be acting directly, but rather must be exerting their eects via the production of one or more intermediate molecules of signaling pathways capable of acting at a distance. These factors have been given various names including, the`second signal' (the term we shall use in this review), factor X and Wnt X (Papayannopoulos et al., 1998; Wehrli and Tomlinson, 1998; Zeidler et al., 1999b) . The identity of a putative second signal has remained elusive despite the fact that a number of predictions regarding the molecular nature and expression pattern of the second signal can be made (Zeidler et al., 1999b) . However, a recent report has described the identi®cation of such a molecule (Zeidler et al., 1999a) . Four jointed (Fj) is a putative secreted type II trans-membrane molecule that is expressed in a broad gradient across the developing eye (Figure 3c ; Brodsky and Steller, 1996; Villano and Katz, 1995) . Both fj gain-and loss-of-function clones produce ommatidial inversion phenotypes as predicted for a diusible second signal proposed to be downstream of the Wingless and JAK/STAT pathways (Zeidler et al., 1999a) . Interestingly, fj expression is regulated by both Upd and the JAK/STAT pathway as would be expected of a bona ®de second signal. fj is down regulated in loss-of-function clones lacking hop and is upregulated in and around clones of cells that misexpress Upd (Figure 3d,e) . Further research is required to determine whether this eect is a direct consequence of Stat92E mediated expression as the promoter region of four jointed has not been analysed, and details regarding the mechanism of activation by the Upd and JAK/STAT pathway are as yet unknown. However, fj appears to ful®l the requirements for a second signal and may well represent another developmentally relevant, in vivo target of the JAK/STAT pathway.
A gradient of JAK/STAT signaling activity across the eye Analysis of an enhancer detector P-element insertion in the stat92E locus has shown this insertion (known as STAT-lacZ) to act as an in vivo reporter of JAK/ STAT pathway activity. The activity of the reporter is inversely proportional to the actual level of JAK/ STAT pathway activity. Clones of cells mutant for hop result in up-regulation of STAT-lacZ while clones of cells ectopically expressing upd strongly downregulate STAT-lacZ, not only within the region of Upd mis-expression, but also in surrounding tissues (Zeidler et al., 1999b) . Based on these ®ndings, it is clear that the pattern of STAT-lacZ in the wild type situation can be used to indicate the level of JAK/ STAT pathway signaling. Such an analysis shows that a clear gradient of JAK/STAT pathway activity exists across the developing eye primordia with highest activity at the midline of the eye imaginal disc and (Zeidler et al., 1999b; H Sun, personal communication) . This ®nding represents one of the clearest correlations between the pattern of Upd and the resultant activity of the JAK/STAT pathway in vivo, further strengthening the link between Upd and its role in the activation of the JAK/STAT pathway. The fact that the gradient of Upd induced JAK/STAT pathway activity (as demonstrated by STAT-lacZ) is central to the correct orientation of ommatidia is supported by experiments in which Upd is mis-expressed. Experiments in which Upd is mis-expressed in domains other than the midline of the disc (where endogenous Upd is present) change the local gradient of JAK/STAT activity and have been shown to result in ommatidial inversion phenotypes (Zeidler et al., 1999b) , presumably via the resultant ectopic expression of the second signal four jointed (Figure 3d,e) . This is the ®rst case in which a gradient of JAK/STAT pathway signaling activity has been shown to exist, to be required for normal development, and to be the result of localized expression of a pathway ligand.
Redundancy in JAK/STAT signaling
Although both hop and stat92E loss of function clones can generate ommatidial inversion phenotypes, the relative strength (or expressivity) of these phenotypes are very dierent. Alleles of stat92E thought to be amorphic (total loss of function) produce eects at a much lower frequency than amorphic alleles of hop (Zeidler et al., 1999b) . It was originally suggested that this dierence in phenotypic strength could be due to partial redundancy between stat92E and other as yet undiscovered Drosophila STAT molecules. However, as discussed above, that explanation now seems increasingly unlikely. As stat92E probably represents the only Drosophila STAT, it is possible that another as yet unidenti®ed mechanism exists downstream of Hop, and parallel to Stat92E. While a potential explanation is simply that an alternative STAT like molecule is too divergent to be identi®ed by sequence searches, the precise nature of the mechanisms that would partially mediate the transduction of Upd initiated Hop signaling remain unidenti®ed.
Future directions
Our understanding of the roles of the JAK/STAT pathway during Drosophila development has advanced considerably in recent years and the study of the pathway is sure to be a source of new and unexpected ®ndings in the years to come. However, a number of outstanding questions remain in our understanding of both the pathway itself, its functions during development and its interactions with other signal transduction cascades. The answers to these questions are likely to lie in a number of directions. While a number of putative additional JAK/STAT pathway components have been identi®ed by homology, many components of this pathway have yet to be identi®ed genetically in ies. Given the genetic nature of the Drosophila system, the generation and identi®cation of mutations in these components will be essential. It is conceivable that screens to identify mutations in these components could be based on a number of dierent aspects of the JAK/STAT pathway. These include further screens designed to identify the characteristic JAK/STAT-like embryonic cuticle phenotype in germline clones, suppression of the dominant phenotypes associated with hop Tum-l or hop T42 mutations or sensitized systems that select candidate mutations by their interaction with an engineered over-activation phenotype. Indeed each of these possibilities either has been, or is being, pursued in a number of laboratories and the next few years should lead to a signi®cant increase in the number of identi®ed, genetically de®ned, JAK/STAT pathway components.
A further major advance in our understanding of JAK/STAT signaling will undoubtedly come from the analysis of other aspects of both embryonic and adult development that require the pathway. These may include other stages and tissues of embryonic development such as the trachaeal pits in which Upd is strongly expressed (Harrison et al., 1998) , larval blood cell development and the insect immune response (Barillas et al., 1999) . Moreover, the analysis of other stages of adult development such as wing vein and wing hinge defects observed to be part of existing partial loss-of-function pathway mutant phenotypes may also prove fruitful.
In addition to these developmental roles, it is becoming increasingly clear that the JAK/STAT pathway cannot function in isolation. Indeed analysis of eve expression in mutant embryos indicates that while the JAK/STAT pathway is undoubtedly important in the regulation of eve stripe 3 expression, additional signals feed in to maintain low levels of eve expression in this third stripe even in the total absence of JAK/STAT activity (Hou et al., 1996; Yan et al., 1996a) . In addition the proper expression of fj in the developing eye is not simply a consequence of Upd/JAK/STAT signaling but rather appears to require the additional involvement of Wingless signaling, Notch activity and an as yet uncharacterized component of fj autocrine feedback (Zeidler et al., 1999a) . No doubt similar complications will arise with regard not only to JAK/STAT signaling, but a wide range of signal transduction responses as the tools available and our resultant understanding of the systems being analysed continue to improve.
One such set of tools which would facilitate our understanding of JAK/STAT signaling would be reagents with which to visualize the activity of the pathway in vivo. While STAT-lacZ is able to report JAK/STAT activity in imaginal discs this does not represent an assay suitable for individual cells or tissue culture based systems and additional techniques would also be useful. Given the recent development and use of antibodies speci®c for activated forms of Drosophila ERK (Gabay et al., 1997) and the commercial availability of phospho-speci®c forms of mammalian STATs, it seems plausible that similar antibodies that recognize activated JAK or STAT could be developed. Alternatively the subcellular translocation of STAT into the nucleus following activation may also provide the basis of such techniques.
